1Kimoto T, Suemitsu K, Nakayama H, Komori E, Ohtani M, Ando S. Therapeutic experience of venomous snakebites by the Japanese viper (Agkistrodon halys Blomhoffii) with low dose of antivenin: report of 43 consecutive cases. Nippon Geka Hokan 1997; 66: 71-7.
2Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y. Seventeen cases of alopecia areata: combination of SADBE topical immuno- therapy with other therapies. J Dermatol 2002; 29: 661-4.
3Furusawa S, Wu J. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases. Life Sci 2007; 80: 1073-9.
4Goto M, Zeller WP, Hurley RM. Cepharanthine (biscoclaurine alkaloid) treatment in endotoxic shock of suckling rats. J Pharm Pharmacol 1991; 43: 589-91.
5Mukai M, Che XF, Furukawa T, Sumizawa T, Aoki S, Ren XQ, et al. Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells. Cancer Sci 2003; 94: 557-63.
6Shiraishi N, Akiyama S, Nakagawa M, Kobayashi M, Kuwano M. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells. Cancer Res 1987; 47: 2413-6.
7Fujimura T, Shibata H, Maekawa I, Furusawa S, Kawauchi H, Sasaki K, et al. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells. Jpn J Pharmacol 1990; 54: 464-7.
8Seubwai W, Vaeteewoottacharn K, Hiyoshi M, Suzu S, Puapairoj A, Wongkham C, et al. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci 2010; 101: 1590-5.
9Wu J, Suzuki H, Zhou YW, Liu W, Yoshihara M, Kato M, et al. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. J Cell Biochem 2001; 82: 200-14.
10Biswas KK, Tancharoen S, Sarker KP, Kawahara K, Hashiguchi T, Maruyama I. Cepharanthine triggers apoptosis in a human hepato- cellular carcinoma cell line (HUH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett 2006; 580: 703-10.
2Leary SES, Wozniak AW, Billups CA, et al. Survival of pedi- atric patients after relapsed osteosarcoma:the St. Jude Chil- dreng Resea/ch Hospital experience [ J 1. Cancer, 2013,119 (14) :2645-2653.
3Halting MT~ Blakely ML, Jaffe N, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma ~ J 1. J Pediatr Surg,2006,41 ( 1 ) : 194-199.
